These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4193338)

  • 21. [Side effects of a depot progestational agent].
    Zeron-Medina F; Romero Garcia F
    Prensa Med Mex; 1970; 35(5):277-9. PubMed ID: 5517102
    [No Abstract]   [Full Text] [Related]  

  • 22. Liver tumours and oral contraceptives.
    Binnie GA
    Lancet; 1980 Mar; 1(8167):549. PubMed ID: 6102275
    [No Abstract]   [Full Text] [Related]  

  • 23. Liver metabolism and contraceptive steroids.
    Brohult J; Westgren A
    Lancet; 1965 Dec; 2(7426):1344. PubMed ID: 4165318
    [No Abstract]   [Full Text] [Related]  

  • 24. Patient acceptance of oral contraceptives. II. The private patient.
    Wallach EE; Watson FM; Garcia CR
    Am J Obstet Gynecol; 1967 Aug; 98(8):1071-9. PubMed ID: 4951889
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of hormonal contraceptives on the activity of various enzymes in blood serum].
    Schädel JM; Rehfeld N
    Z Med Lab Diagn; 1985; 26(2):77-85. PubMed ID: 3993167
    [No Abstract]   [Full Text] [Related]  

  • 26. [Influence of oral contraceptives on quantitavely measured plasma proteins].
    Bachmann GW; Gleichmann W
    Verh Dtsch Ges Inn Med; 1971; 77():573-7. PubMed ID: 5005533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of oral contraceptives on liver function and structure].
    Andree H; Roschlau G
    Z Arztl Fortbild (Jena); 1987; 81(21):1095-104. PubMed ID: 3328430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alteration of cephalin-cholesterol flocculation in patients taking oral contraceptive agents.
    Keidan H
    Can Med Assoc J; 1966 May; 94(19):1014. PubMed ID: 4952387
    [No Abstract]   [Full Text] [Related]  

  • 29. [Features of liver damage caused by 17-alpha-alkyl-substituted anabolic steroids].
    Lovisetto P; Mairano D; Actis GC; Marchi L
    Minerva Med; 1979 Mar; 70(11):769-90. PubMed ID: 372848
    [No Abstract]   [Full Text] [Related]  

  • 30. [Changes in the function of the liver after use of synthetic progestins].
    Manuilova IA; Melkumova IS; Evdokimova VI; Saluén'ia AI
    Ter Arkh; 1974; 46(4):14-20. PubMed ID: 4610867
    [No Abstract]   [Full Text] [Related]  

  • 31. Oral contraceptives and the liver.
    Br Med J; 1974 Nov; 4(5942):430-1. PubMed ID: 4473247
    [No Abstract]   [Full Text] [Related]  

  • 32. [Evaluation of various liver function and blood coagulation tests in early stages of treatment with oral contraceptives].
    Del Vecchio-Blanco C; Rinaldi M; Saffiotti O; Moro CO; Albanese R; De Maria C
    Clin Ter; 1978 Nov; 87(3):233-42. PubMed ID: 753573
    [No Abstract]   [Full Text] [Related]  

  • 33. [Editorial: Hepatic effects of oral contraceptives].
    Métreau JM; Berthelot
    Arch Fr Mal App Dig; 1973; 62(5):365-8. PubMed ID: 4805682
    [No Abstract]   [Full Text] [Related]  

  • 34. Jaundice with Dubin-Johnson-Sprinz syndrome precipitated by oral contraceptives.
    Schinella RA
    N Y State J Med; 1972 Nov; 72(22):2810-3. PubMed ID: 4510720
    [No Abstract]   [Full Text] [Related]  

  • 35. [Liver function in hormonal contraception].
    Patt V
    Fortschr Med; 1976 Nov; 94(33):1900-6. PubMed ID: 825425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Apropos of biological and histological anomalies of the liver associated with oral contraceptives. Note on the behaviour of biliary salts, BSP and indocyanine green].
    Caroli J; Chevrel B; Rautureau M; Lemonnier F; Lévy VG; Hecht Y
    Pathol Biol; 1968 Nov; 16(21):935-42. PubMed ID: 4888085
    [No Abstract]   [Full Text] [Related]  

  • 37. [Side effects of oral contraceptives].
    Cottier P
    Schweiz Med Wochenschr; 1972 Jun; 102(24):821-8. PubMed ID: 5033619
    [No Abstract]   [Full Text] [Related]  

  • 38. [Liver disease with jaundice due to pregnancy and oral contraceptives. Clinical, functional and histomorphological considerations].
    Paci P; Cirri GP; Tafani O
    Policlinico Med; 1972; 79(1):31-50. PubMed ID: 5063336
    [No Abstract]   [Full Text] [Related]  

  • 39. [Basically, is there a possibility for therapy with ovulation inhibitors in hepatitis C with virus persistence and in the acute stage?].
    Gerken G
    Internist (Berl); 1995 Apr; 36(4):410-1. PubMed ID: 7775094
    [No Abstract]   [Full Text] [Related]  

  • 40. [Letter: Laboratory follow-up of women taking contraceptives].
    Zentai A; Gógl A; Hasitz S; Fendler K
    Orv Hetil; 1973 Dec; 114(50):3054. PubMed ID: 4769426
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.